Eye Health Academy

Improving Clinical
Decision Making with
Engaging CME, Tools,
& Resources

Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Eye on Ocular Health
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Outcomes for PDR Patients LTFU for at Least 1 Year
Outcomes for PDR Patients LTFU for at Least 1 Year
Ophthalmology
Outcomes for PDR Patients LTFU for at Least 1 Year
- Kyle Davis Kovacs, MD
- Matt Starr, MD
- Nita Valikodath, MD, MS
Examining Therapeutic Timing in RVO-Related Macular Edema
Examining Therapeutic Timing in RVO-Related Macular Edema
Eye on Ocular Health
Examining Therapeutic Timing in RVO-Related Macular Edema
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Ophthalmology
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
- Maria H. Berrocal, MD
- Lejla Vajzovic, MD, FASRS
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- Esther Lee Kim, MD
0.25 credits
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- Deepak Sambhara, MD
0.25 credits
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- David Chin Yee, MD, FASRS
0.25 credits
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- David Eichenbaum, MD
0.25 credits

Clinical Practice

GLP-1 Use and AMD Risk
GLP-1 Use and AMD Risk
Ophthalmology
GLP-1 Use and AMD Risk
- Barton Lynn Blackorby, MD
- Katharine Talcott, MD
- Hong-Uyen Hua, MD
MH Risk Factors After RRD Repair
MH Risk Factors After RRD Repair
Ophthalmology
MH Risk Factors After RRD Repair
- Maria H. Berrocal, MD
- Avni P. Finn, MD, MBA
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Eye on Ocular Health
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
- Ashkan Abbey, MD
Retinal Vein Occlusion: The Case for Prompt Treatment
Retinal Vein Occlusion: The Case for Prompt Treatment
Eye on Ocular Health
Retinal Vein Occlusion: The Case for Prompt Treatment
- Ashkan Abbey, MD
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Eye on Ocular Health
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
- Ryan Quigley
Redefining The Cash-Pay Model in Modern Optometric Practice
Redefining The Cash-Pay Model in Modern Optometric Practice
Modern Optometry
Redefining The Cash-Pay Model in Modern Optometric Practice
- Jason E. Compton, OD, FAAO
Elevating Clinical Efficiency
Elevating Clinical Efficiency
Modern Optometry
Elevating Clinical Efficiency
- Diana Chu
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Eye on Ocular Health
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
- Jennifer Caudle, DO, FACOFP
- Michael Javaheri, MD, MSc, FASRS

Popular

Clinical Practice

Title

Share on ReachMD